24 October 2024

Pain

Opioid trial in Lancet wins ANZMUSC gong

24 October 2024

Biologics Bullous Pemphigoid

‘Breakthrough’ mAb in moderate to severe bullous pemphigoid

24 October 2024 SPONSORED

Musculoskeletal podcast

New option for psoriatic arthritis and axial spondyloarthritis

24 October 2024

The Back Page

Men in pain depend on opioids, women not so much

24 October 2024

Technology TGA

TGA warns medical device users ahead of 3G shutdown

24 October 2024

ageing Epidemiology

Life expectancy growth lags for Australians under 50

24 October 2024

Conference Rheumatology

A3BC rocks Adelaide for annual meeting

24 October 2024

Genetics Gout Research

Gout genetics gets to source of inflammation

24 October 2024

Systemic sclerosis

Raynaud’s not just a cold weather concern

10 October 2024

The Back Page

DoHAC’s spring cleaning spree

10 October 2024

AHPRA Political Workforce

AHPRA’s expedited IMG rego system nowhere in sight

10 October 2024

Hidradenitis Suppurativa Research

Semaglutide offers hope for rare skin disease

10 October 2024

PBS Pharmaceuticals Psoriatic Athritis Spondyloarthritis

Bimekizumab added to PBS for PsA and axSpA patients

10 October 2024

Lupus Pharmaceuticals Research

Phase 3 trial success for two new lupus meds

10 October 2024

Digital Health Osteoarthritis Research

Haleon, USyd team up for new osteoarthritis fellowship

10 October 2024

PBS Pharmaceuticals

Flurry of rheum PBS listings